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A B S T R A C T   
Characterizing neuroanatomical markers of different stages of schizophrenia (SZ) to assess pathophysiological 
models of how the disorder develops is an important target for the clinical practice. We performed a meta- 
analysis of voxel-based morphometry studies of genetic and clinical high-risk subjects (g-/c-HR), recently 
diagnosed (RDSZ) and chronic SZ patients (ChSZ). We quantified gray matter (GM) changes associated with these 
four conditions and compared them with contrast and conjunctional data. We performed the behavioral analysis 
and networks decomposition of alterations to obtain their functional characterization. Results reveal a cortical- 
subcortical, left-to-right homotopic progression of GM loss. The right anterior cingulate is the only altered region 
found altered among c-HR, RDSZ and ChSZ. Contrast analyses show left-lateralized insular, amygdalar and 
parahippocampal GM reduction in RDSZ, which appears bilateral in ChSZ. Functional decomposition shows 
involvement of the salience network, with an enlargement of the sensorimotor network in RDSZ and the 
thalamus-basal nuclei network in ChSZ. These findings support the current neuroprogressive models of SZ and 
integrate this deterioration with the clinical evolution of the disease.   
1. Introduction 
Schizophrenia (SZ) is a severe psychiatric disorder with a typical 
onset in late adolescence or early adulthood (Owen et al., 2016). The 
disability-associated burden of SZ was 13.4 million years lived with 
disability (YLDs) worldwide, equivalent to 1.7 % of global YLDs in 2016 
(Charlson et al., 2018). 
Considered the heavy burden of SZ, a better comprehension of the 
pathophysiology of this disorder is needed to improve treatments and 
outcomes (Wojtalik et al., 2017). Various current pathophysiological 
paradigms consider SZ as a neurodevelopmental disease with a pro-
gressive peculiar neurodegenerative component characterized by 
reduced dendritic spines density, altered synaptic homeostasis and glial 
dysfunction in the absence of gliosis and neuronal necrosis (Andreasen, 
2010; Ashe et al., 2001; Buoli et al., 2017; Velakoulis et al., 2000). 
According to this hypothesis, specific abnormalities, taking place in 
precise brain development stages, are associated with SZ onset and 
followed by processes of brain aging acceleration (Buoli et al., 2017; 
Nenadic et al., 2017). This type of brain alteration can manifest as a 
progressive reduction in the gray matter (GM) volume of specific neural 
territories. SZ could be staged from an increased risk of developing 
psychosis, with milder observable neurobiological and clinical expres-
sions, to a persistent and unremitting condition with more evident signs 
of neurodegeneration (Davis et al., 2014; McGorry et al., 2006; Ortiz 
et al., 2017; Wood et al., 2011). 
In-vivo neuroimaging techniques have provided an unprecedented 
insight into the brain alterations underlying neuropsychiatric disorders. 
Among them, one of the most employed approaches is the structural 
* Corresponding author at: Department of Psychology, University of Turin, via Giuseppe Verdi 10, 10124, Torino, Italy. 
E-mail addresses: donato.liloia@unito.it (D. Liloia), claudio.brasso@unito.it (C. Brasso), franco.cauda@unito.it (F. Cauda), lorenzo.mancuso@unito.it 
(L. Mancuso), andrea.nani@unito.it (A. Nani), jordi.manuello@unito.it (J. Manuello), tommaso.costa@unito.it (T. Costa), ducasergio@osp-koelliker.it (S. Duca), 
paola.rocca@unito.it (P. Rocca).  
Contents lists available at ScienceDirect 
Neuroscience and Biobehavioral Reviews 
journal homepage: www.elsevier.com/locate/neubiorev 
https://doi.org/10.1016/j.neubiorev.2021.01.010 
Received 15 June 2020; Received in revised form 7 January 2021; Accepted 15 January 2021   
Neuroscience and Biobehavioral Reviews 123 (2021) 83–103
84
magnetic resonance imaging (sMRI) with voxel-based morphometry 
(VBM) (Isobe et al., 2016). VBM allows the detection of GM focal vari-
ations (i.e. volume or concentration) between-subject groups compari-
sons by means of a quantitative and voxel-wise analysis (for a detailed 
explanation of the method see Ashburner and Friston, 2000). Starting 
from the seminal work of Wright et al. (1995), widespread morpho-
metric reductions have been repeatedly reported in groups of patients 
with SZ compared to healthy controls (HC). Importantly, some abnor-
malities have been observed both at first presentation and in the chronic 
stage of illness. In this regard, the systematic review of Shepherd et al. 
(2012) suggested that multiple GM degenerations occur regardless of SZ 
stages, encompassing the insulae, frontal gyri (particularly the inferior 
and medial ones), right anterior cingulate and superior temporal 
cortices. However, the conclusive picture of shared brain markers was 
limited by the heterogeneity quality of voxel-based investigations being 
reviewed (Shepherd et al., 2012). Moreover, some authors detected 
volumetric loss only in isolated cerebral loci (Ferri et al., 2012; Naka-
mura et al., 2013; Zhang et al., 2015) or even clusters of GM increase 
(Oertel-Knöchel et al., 2012; Sheng et al., 2013; Watson et al., 2012). 
Despite substantial advances in sMRI research on SZ, replicability of 
results is still far from satisfactory (Hager and Keshavan, 2015; John 
et al., 2015; Kochunov et al., 2019). Potential sources of variability in 
findings may be partially due to differences in the assessed clinical 
population in terms of duration of illness (recently diagnosed or chronic 
SZ vs. mixed) (Torres et al., 2016), diagnoses included (only SZ vs. SZ 
spectrum disorders) (Fervaha and Remington, 2013; Rink et al., 2016; 
Velakoulis et al., 2006), medical comorbidities or substance abuse (Bora 
et al., 2017; Koenders et al., 2015), gender distribution (Bora et al., 
2012), medication status (antipsychotic-naïve vs. -treated) (Torres et al., 
2013), age and type of symptomatology (Koutsouleris et al., 2014). 
Other confounding factors could derive from methodological choices 
regarding the type of analysis (whole-brain vs. region of interest - ROI or 
small volume correction -SVC) (McDonald et al., 2008; Voormolen et al., 
2010), acquisition protocols (Jovicich et al., 2009), preprocessing soft-
ware packages (Li et al., 2019a), sample size (small vs. multicenter 
mega-analyses) (Torres et al., 2016) and statistical thresholding pro-
cedures (Bennett et al., 2009; Vijayakumari et al., 2015). 
Given these many confounding factors in the between-group com-
parisons, an objective assessment is needed to provide robust findings 
and summarize the recent growing literature about neuroanatomical 
alterations in SZ. A powerful approach is the quantitative synthesis of 
published neuroimaging results by means of coordinate-based meta- 
analysis (CBMA). In particular, the anatomical likelihood estimation 
(ALE) represents the most widely employed technique in the CBMA field 
(Tahmasian et al., 2019) and is able to quantify convergent morpho-
metric alterations of neuropsychiatric disorders in a fully automated and 
replicable manner (Eickhoff et al., 2012). The ALE provides a rigorous 
environment to estimate the probability of spatial-unbiased distribution 
maps across experiments, mitigating the laboratory and group-level 
inhomogeneity (Fox et al., 2014). 
This technique and other CBMA approaches have been usefully 
employed in the last two decades, suggesting that distributed cortical, 
subcortical and cerebellar GM alterations are involved in SZ spectrum 
disorders (Bora et al., 2011; Chan et al., 2011; Ellison-Wright and 
Bullmore, 2010; Ellison-Wright et al., 2008; Fornito et al., 2009; Glahn 
et al., 2008; Li et al., 2018; Nickl-Jockschat et al., 2011). Also, the 
presence of aberrations in unaffected relatives of patients with SZ 
(genetic-risk) and in individuals at risk of psychosis (clinical-risk) has 
been convincingly highlighted (Fusar-Poli et al., 2011a, 2014; Saarinen 
et al., 2020). Although these meta-analytic findings are relevant, a 
considerable variability and inconsistency persist due to heterogeneity 
in the examined hypothesis and/or clinical sub-populations, different 
inclusion/exclusion criteria and, consequently, in the number of the 
analyzed experiments. In addition, certain important issues remain to be 
addressed. 
Previous CBMAs systematically included several VBM experiments 
comparing HC with a mixed experimental group composed of in-
dividuals with SZ and of others with diagnoses belonging to the SZ 
spectrum disorders (SSD), so that the “pure” contribution of the diag-
nosis of SZ in GM alterations was not completely explored. For this 
reason, samples including patients diagnosed with SSD were not 
included in the present CBMA. The choice to focus on the SZ diagnosis 
only meets the need for identifying patterns of GM alterations that are 
specific to SZ. Furthermore, given that SZ is the most represented mental 
disorder in terms of number of sMRI studies and SZ diagnostic criteria 
are relatively stable over time and between nosological classifications, 
samples studied in different periods tend to be homogeneous. 
We also decided to examine genetic and clinical high-risk (HR) states 
for psychosis because these two pre-psychotic conditions, albeit not 
necessarily evolving to psychosis, are characterized by GM alterations, 
which are not always consistent across studies (Cooper et al., 2014; 
Saarinen et al., 2020). From a clinical perspective, the detection of 
consensual neuroanatomical modifications can facilitate a prompt 
identification of these conditions by assessing their role in the transition 
to full-blown psychosis, as well as allow more effective strategies for 
prevention and care. Moreover, a number of studies on these HR samples 
are now available and sufficient to perform a robust CBMA. 
Observer-independent functional characterization of the GM loss in 
different stages of SZ is essential in order to better understand how large- 
scale brain networks are involved in different periods of the disease 
progression. It is also of fundamental importance to control clinical, 
socio-demographic and methodological effects on VBM results in SZ 
(John et al., 2015; Kakeda and Korogi, 2010; Kambeitz et al., 2015; 
Vijayakumari et al., 2015). To our knowledge, no previous CBMAs on 
aberrant morphometric patterns linked to mental domains have been 
carried out so far. This line of research would provide a quantitative 
description of the functional and behavioral impact of anatomical var-
iations at different stages of the disorder. 
Another important aspect concerns the recent methodological in-
novations for the CBMA and the publication of best-practice protocols 
for this field. In 2017 the BrainMap team reported some technical errors 
affecting the ALE algorithm as implemented in GingerALE software, 
whose codes for the thresholding procedure may have increased the rate 
of false positives (Eickhoff et al., 2017). Still, different authors (Eickhoff 
et al., 2017, 2016; Müller et al., 2017; Samea et al., 2019) have strongly 
discouraged the use of the previously customary false discovery rate 
(FDR) voxel-level thresholding in the context of ALE meta-analyses, 
advising instead the use of cluster-level family-wise error (FWE) 
thresholding, given its better sensitivity to true effects. Great care was 
recommended regarding the inclusion of studies to enhance reliability 
and reproducibility, as well as to facilitate subsequent research efforts 
(Müller et al., 2018; Nichols et al., 2017; Tahmasian et al., 2019). In 
light of this, computational, statistical and reporting advances support 
the need to carry out a novel meta-analytic investigation. This is 
particularly true for an updated and extended estimation on different SZ 
stages, as the most recent ALE analysis on this topic dates back to 2011 
(Chan et al., 2011) and many new relevant VBM studies were published 
since then. 
We therefore conducted an exhaustive systematic search to revisit 
and characterize spatially consistent GM variations in four clinical 
groups: genetic high-risk subjects (g-HR), clinical high-risk subjects (c- 
HR), patients recently diagnosed with SZ (RDSZ, with a duration of 
illness - DOI < 2 years), and chronic SZ patients (ChSZ, DOI ≥ 2 years). 
The present ALE study is based on the largest data set of whole-brain 
VBM results included so far about this topic, on restrictive inclusion 
criteria, on stringent statistical procedure and on the most recent 
consensus-based protocols. Our aim has been to establish the most 
consistent neuroanatomical abnormalities related to the subsequent 
phases of the SZ. In order to derive common and potentially distinctive 
brain markers, contrast meta-analyses were conducted between the 
different groups. We also examined the effects of socio-demographic, 
clinical and methodological variables through voxel-wise meta-re-
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gressions. Finally, we assessed the cognitive/behavioral profiles asso-
ciated with the GM clusters of alteration identified by the ALE. This 
combination of morphometric localization and functional character-
ization allowed for observer-independent inference, thus linking statis-
tically the SZ pathophysiology to its clinical manifestations. 
2. Methods 
2.1. Data identification 
The study protocol adhered to the PRISMA Statement international 
guidelines (Moher et al., 2009) and current consensus recommendations 
for neuroimaging CBMA (Müller et al., 2018; Tahmasian et al., 2019). 
We employed the software application Sleuth (v.3.0.3) to query the VBM 
database of BrainMap (December 1, 2019) (Vanasse et al., 2018). We 
assembled a standardized search algorithm as follow:  
• “Experiments Context IS Disease Effects” AND “Subjects Diagnosis IS 
Schizophrenia” AND “Experiments Contrast IS Gray Matter” AND 
“Experiments Observed Changes IS Controls > Patients AND 
Controls < Patients”. 
We also employed the PubMed search engine to perform a systematic 
literature search on the MEDLINE database. We used the Advanced 
Search Builder adopting the following terms to search in title/abstracts:  
• (“voxel-based morphometry” OR “VBM” OR “voxel-wise”) AND 
(“schizophrenia” OR “chronic schizophrenia” OR “SZ” OR “first 
episode schizophrenia” OR “first episode psychosis” OR “high risk 
schizophrenia” OR “siblings schizophrenia” OR “first degree relatives” 
OR “genetic risk schizophrenia” OR “at risk of mental state” OR 
“ARMS” OR “ultra-high risk”). 
As final step, we screened references consulting previous review 
articles (Birur et al., 2017; Shepherd et al., 2012) and CBMAs about the 
conditions of interest (Chan et al., 2011; Ellison-Wright et al., 2008; 
Fusar-Poli et al., 2011a, 2014). 
2.2. Data selection 
The identified articles were systematically reviewed. Inclusion 
criteria for neuroimaging experiments were: (a) to be included in a 
research article published in a peer-review journal; (b) to use a specified 
whole-brain VBM analysis; (c) to report GM variations in HR subjects 
and/or patients with RDSZ and/or patients with ChSZ by means of a 
between-group comparison with healthy controls; (d) to report results in 
the form of stereotactic space (i.e. x,y,z coordinates in Talairach or MNI 
space); (e) to adopt analyses corrected for multiple comparisons or 
cluster-wise extent thresholds >100 voxels; (f) experimental group 
without other medical comorbidities; (g) diagnosis of SZ based on ful-
filling ICD or DSM criteria. 
Moreover, we applied rigorous and restrictive exclusion criteria ac-
cording to which we excluded the articles with one or more of the 
following characteristics: (a) experimental groups with a sample size <
10 subjects; (b) use of ROI or SVC analysis; (c) mixed experimental 
sample (i.e. SZ and other SDDs and/or RDSZ and ChSZ). Still, to avoid 
the possibility of analyzing the same subjects several times in a single 
study, we selected only the alteration foci reported by the analysis with 
the largest sample of that study. Furthermore, to prevent redundancy of 
subjects and related results across studies by the same authors we 
selected only the last study (more recent publication date) published by 
the same research group with the same sample. Detailed reporting of 
inclusion and exclusion criteria can be found in the best-practice 
checklist (Table S1). 
2.3. Clinical groups definition 
Following the seminal ALE study of Chan et al. (2011), we parti-
tioned our data set into distinct clinical groups: HR, RDSZ and ChSZ. 
However, we divided HR subjects into two groups (genetic and clinical 
HR) according to the model proposed by Fusar Poli et al. (2011a). The 
HR sample consisted of subjects at risk of developing SZ and was 
composed by the genetic HR group (g-HR) represented by monozygotic 
twins, siblings and first/second-degree relatives of patients with SZ and 
the clinical HR group (c-HR) of individuals at risk mental state (ARMS) 
meeting the criteria of either the Personal Assessment and Crisis Eval-
uation (PACE) (Yung et al., 1998), the Comprehensive Assessment of 
At-Risk Mental States (CAARMS) (Yung et al., 2005) or the Structured 
Interview for Prodromal Symptoms (SIPS) (Miller et al., 2003). The 
RDSZ group was composed of subjects with DOI less than 2 years. In the 
ChSZ group, patients had DOI equal or greater than 2 years. We included 
investigations that, though not reporting the DOI, referred clearly to a 
whole RDSZ or ChSZ sample. 
2.4. Anatomical likelihood estimation 
A series of ALE meta-analyses was conducted to determine a 
consistent pattern of GM variations for each of the four clinical groups 
and for all schizophrenia patients. A revised version of the ALE algo-
rithm implemented in GingerAle (v.3.0.2) was applied (Turkeltaub 
et al., 2012). Following the recently recommended ALE setting (Eickhoff 
et al., 2017, 2016), ALE results were family-wise error-corrected 
(FWE-c) for multiple comparisons, with a cluster-level inference of 
p < .05 and a cluster-forming threshold of p < .001 on the voxel-level. 
We conducted analyses in Talairach space. Thus, we used the icbm2tal 
algorithm to convert the MNI coordinates into TAL space, improving the 
accuracy of meta-analysis (Lancaster et al., 2007). 
The ALE technique provides information about the spatial conver-
gence of results of the existing literature, considering every coordinate 
reported in a given study as being the center of a Gaussian probability 









in which d is the Euclidean distance between the coordinate and the 
surrounding voxels, and σ represents the spatial uncertainty. For each 
experiment we calculated a modeled alteration (MA) map, considered as 
the union of every Gaussian distribution of probability related to a given 
experiment. The combination of all the MA maps resulted in the final 
ALE map. The significance of each voxel was then tested against a null 
hypothesis obtained by an iterative random distribution of the foci, and 
the cluster-level threshold was determined with a Monte Carlo simula-
tion of a cluster size distribution (10,000 permutations). 
Finally, contrast analyses were performed (Eickhoff et al., 2011) in 
order to identify statistically significant differences and convergence 
between the clinical groups using a p < .01 and minimum cluster-size of 
10 mm3 (10,000 permutations). 
2.5. Standard voxel-wise permutation tests 
We further interrogated the presence of GM variations in our clinical 
groups by using voxel-wise permutation tests as implemented in the 
FSL’s randomise algorithm (https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/ 
Randomise; Winkler et al., 2014). Starting from the unthresholded MA 
maps, this algorithm was able to conduct a standard permutation of 
subject-based images (PSI) to test the presence/absence of the effect in a 
given voxel, rather than testing the convergence of independent findings 
around the voxel as implemented in the current CBMA methods (Alba-
jes-Eizagirre and Radua, 2018; Albajes-Eizagirre et al., 2019). For each 
clinical group, results of test statistics were family-wise error-corrected 
D. Liloia et al.                                                                                                                                                                                                                                   
Neuroscience and Biobehavioral Reviews 123 (2021) 83–103
86
(FWE-c) for multiple comparisons on the cluster-level with 5,000 per-
mutation runs. Maps were thresholded at p < .05, corresponding to a 
z-score value ≥ 2.3. 
2.6. Behavioral characterization 
Analysis of behavioral domain profiles aims to statistically link 
morphometric clusters with corresponding physiological mental pro-
cesses by testing which functional neuroimaging task is more likely to 
activate a given cluster. The rationale behind this approach is to provide 
a quantitative and data-driven attribution of psychological processes to 
neural subpopulations, respect to a qualitative interpretation of struc-
tural results. 
We functionally characterized areas of alteration derived by our ALE 
meta-analyses using the Behavioral plugin (v.3.1) implemented in the 
Mango software package (Lancaster et al., 2012), capable of testing 
activation foci of the BrainMap database. At the time of analysis, 
BrainMap contained over 9400 functional experiments in healthy sub-
jects, each of which has been classified according to the specific mental 
operations isolated by its experimental contrast into five behavioral 
domains: (1) cognition, which comprises neuro- and social cognition, 
with special attention to two cognitive processes: memory and language; 
(2) perception, referred to external stimuli such as auditory and visual 
stimuli; (3) interoception, referred to internal stimuli such as hunger, 
heartbeat and sexual libido; (4) emotion, comprising positive and 
negative emotions; and (5) action, defined as mental faculty associated 
with overt movements of the body. Mental operations are further 
divided into 51 subdomains (see full taxonomy list at http://brainmap. 
org/taxonomy/behaviors.html) belonging to the five aforementioned 
domains. 
Behavioral analyses were performed separately on each clinical 
group both on the entire pattern of alteration at a whole-brain level and 
on each derived ALE cluster. A threshold of p < .05 with Bonferroni 
correction for multiple comparisons was applied, corresponding to a 
subdomain z-score ≥ 3. 
2.7. Network decomposition 
We investigated the impact of GM alterations on functional large- 
scale networks, detecting how many altered volumes (mm3) derived 
from the ALE map of each clinical group fell within different networks. 
The rationale behind this approach is to provide a quantitative 
description of the functional localization of anatomical variations, as 
well as to evaluate a possible evolution and enlargement of the pattern 
at different stages of the disorder. We applied the 20-network parcel-
lation proposed by Biswal et al. (2010), which parceled human brain 
cortex using resting-state functional MRI data from 1414 healthy sub-
jects. Decomposition analyses were carried out separately for each 
clinical group, calculating the number of altered volumes belonging to 
each of the 20 functional networks and the percentage of alterations of 
each network, defined as the ratio between the number of altered voxels 
belonging to a given network and the total number of altered voxel of 
the ALE map of GM decrease of that clinical group. 
2.8. Meta-regression 
Using the Signed Differential Mapping software (i.e. anisotropic 
kernel effect sizes version, AES-SDM, v.6.12) (Radua et al., 2014), a 
series of voxel-wise meta-regression analyses were conducted to explore 
the potential effects of gender, positive and negative symptoms, age and 
antipsychotic treatment in the whole SZ sample. Effects of sample size, 
MRI field strength, slice thickness and image smoothing level were also 
examined. VBM experiments that did not report these measures were 
excluded from analyses. A voxel-level threshold of p < .0005 with a 
minimum cluster size of 10 voxels was adopted as proposed by Radua 
et al. (2012), to offer an optimal balance of specificity and sensitivity in 
terms of results. 
AES-SDM is a relatively new CBMA method that borrows several 
characteristics from ALE, particularly the kernel-based rationale and the 
implementation of the coordinate-based random-effects approach; it is 
therefore able to combine the information of alteration foci in stereo-
tactic space across independent experiments (for a detailed explanation 
of the methods see also Radua and Mataix-Cols, 2012; Samartsidis et al., 
2017). The novelty of SDM consists in incorporating t-value statistics 
related to alteration foci (i.e. effect size estimation), and in the possi-
bility of addressing the confounding effect of potential moderators 
across included experiments. Meta-regression investigation was con-
ducted via AES-SDM, as we thought it could complement our main an-
alyses for two reasons: (a) meta-regression is to date a largely 
unexplored topic in CBMA research, particularly valuable when 
meta-analyzed experiments exhibit an appreciable heterogeneity 
(Samartsidis et al., 2017), as it is the case of SZ; (b) the comparison 
between the ALE and SDM yielded similar results in term of spatial 
convergence for both simulated and empirical data sets (Albrecht et al., 
2019; Eickhoff et al., 2016; Enge et al., 2020; Radua and Mataix-Cols, 
2012; Samartsidis et al., 2017; Vitolo et al., 2017). We thus expect 
that ALE map related to the whole SZ group is indicative of AES-SDM 
method as well. 
3. Results 
Based on the search strategy, 113 peer-reviewed VBM articles were 
included, for a total of 124 between-group experiments, 11,270 subjects 
(5,263 in the four clinical groups and 6,007 HC) and 1,104 coordinates 
of GM variation (1,042 of decrease and 62 of increase) (Fig. 1). 
In details, the g-HR group (average age = 28.7 years) included 18 
experiments, 927 subjects compared with 910 HC and 76 coordinates of 
alteration (64 of GM decrease and 12 of GM increase). The c-HR group 
(average age = 22.4 years) included 16 experiments, 580 subjects 
compared with 621 HC and 67 coordinates of alteration (59 of GM 
decrease and 8 of GM increase). The RDSZ group (average age = 22.8 
years; mean illness duration = 0.8 years) included 41 experiments, 
1,636 subjects, 1,953 HC and 388 coordinates of alteration (359 of GM 
decrease and 29 of GM increase). The ChSZ group (average age = 38.6 
years; mean illness duration = 15.0 years) included 49 experiments, 
2,120 subjects, 2,563 HC and 573 coordinates of alteration (560 of GM 
decrease and 13 of GM increase). The best-practice checklist for CBMA 
(Müller et al., 2018) was reported in Table S1. Detailed information 
about the sample of each included experiment is summarized in 
Tables S2 and S3. Distribution of the included experiments in the four 
clinical groups is summarized in Table S4. 
ALE analysis was performed only for GM reduction foci, as the 
number of VBM experiments reporting GM increases (i.e. g-HR = 6 ex-
periments; c-HR = 4; RDSZ = 7; ChSZ = 7; Table S3) was insufficient to 
achieve robust ALE estimates (Eickhoff et al., 2016). 
3.1. ALE meta-analyses on different stages of schizophrenia 
GM reductions in g-HR, c-HR, RDSZ and ChSZ groups relative to HC 
are shown in Table 1 and Figs. 2–4. Results of the ALE meta-analysis 
performed on the whole sample of patients diagnosed with schizo-
phrenia (RDSZ and ChSZ groups pooled together) are shown in Table S5 
and Fig. S1. 
3.1.1. g-HR vs. controls 
The g-HR group showed no significant cluster of variation. 
3.1.2. c-HR vs. controls 
The c-HR group showed a single cluster of GM reduction (altered 
volume = 800 mm3), with the ALE maximum value located in the right 
anterior cingulate cortex (R-ACC, Brodmann area -BA 32). 
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3.1.3. RDSZ vs. controls 
The RDSZ group showed seven clusters of GM reduction involving 
both cortical and subcortical regions with total altered GM volume of 
8,360 mm3. ALE maxima were found in the: (a) left precentral gyrus (L- 
PrCG, BA 6), (b) left inferior frontal gyrus (L-IFG, BA 47), (c) bilateral 
superior temporal gyrus (STG, BA 22), (d) bilateral transverse temporal 
gyrus (TTG, BA 41), (e) right middle temporal gyrus (R-MTG, BA 21), (f) 
bilateral insular cortex (BA 13), (g) bilateral ACC (BA 32), (h) left par-
ahippocampal gyrus (L-PHG, BA 34), and (i) left amygdala (L-Amy). 
3.1.4. ChSZ vs. controls 
Patients of the ChSZ group differed from HC in GM reduction in 
several cortical and subcortical regions grouped into seven clusters with 
a total altered GM volume of 14,912 mm3. ALE maxima were found in 
the: (a) right medial frontal gyrus (R-MFG, BA 11), (b) L-IFG (BA 47), (c) 
L-STG (BA 22), (d) bilateral anterior insula (AI, BA 13), (e) bilateral ACC 
(BA 32/25), (f) bilateral amygdala, (g) head of the left caudal nucleus (L- 
Caud) and (h) medial dorsal nucleus (MDN) of the left thalamus (L- 
Thal). 
3.2. Between-groups comparisons and conjunction analyses 
Results of contrast and conjunction ALE analyses are shown in 
Table 2 and Fig. 5. 
3.2.1. c-HR vs. RDSZ 
c-HR U RDSZ: the conjunction analysis of c-HR and RDSZ groups 
showed a significant convergence of GM reductions in the R-ACC (BA 
32) with a volume of common GM reduction of 144 mm3. 
c-HR < RDSZ: in the between-group comparison there were not sig-
nificant GM reduction present exclusively in the c-HR as compared to 
the RDSZ group. 
RDSZ < c-HR: contrariwise, there were significant reductions in four 
clusters regarding the RDSZ group as compared to the c-HR group. The 
total GM volume altered exclusively in the RDSZ group was 2,600 mm3 
with ALE maxima located in the left hemisphere, principally in cortical 
areas in the frontal lobe: (a) in the L-IFG (BA 44) and (b) in the L-PrCG 
(BA 4); (c) in the left postcentral gyrus (L-PoCG, BA 43); (d) in the L-STG 
(BA 22); in (e) the L-AI (BA 13) and (f) in the left claustrum (L-Clau). 
Fig. 1. Study selection overview and meta-data organization - PRISMA flow chart. 
g-HR: genetic high-risk; c-HR: clinical high-risk; RDSZ: recently diagnosed schizophrenia; ChSZ: chronic schizophrenia. 
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3.2.2. RDSZ vs. ChSZ 
RDSZ U ChSZ: the conjunction analysis of RDSZ and ChSZ groups 
showed five significant clusters of convergence of GM reductions in the 
left hemisphere (total volume of common GM reduction: 1,184 mm3), 
namely (a) the L-PrCG (BA 6) and (b) the orbital part of the L-IFG (L-IFG, 
BA 44) in the frontal pole, (c) the L-AI (BA 13), (d) the L-ACC (BA 32), 
extending to right ACC and (e) the L-Amy. 
RDSZ < ChSZ: in the between-group comparison there were three 
clusters of significant reduction regarding the RDSZ group as compared 
to the ChSZ group (total volume of altered GM present exclusively in the 
RDSZ: 672 mm3), with ALE maxima located in the: (a) L-IFG (BA 44), (b) 
L-PrCG (BA 6), (c) L-PoCG (BA 43), (d) L-AI (BA 13); and right temporal 
lobe (e) in the R-MTG (BA 21). ChSZ < RDSZ: conversely, ChSZ group as 
compared to RDSZ group showed significant GM decreases in five 
clusters (total volume of altered GM present exclusively in the ChSZ: 
1,464 mm3) with ALE maxima located both in the left and right hemi-
spheres in cortical and sub-cortical encephalic regions. In particular, 
ChSZ specific peaks of alteration were found in the: (a) L-IFG (BA 44), 
(b) L-STG (BA 22); (c) in bilateral AI (BA 13), (d) R-PHG (BA 34), (e) the 
right uncus (R-Unc, BA 34); (f) MDN and (g) pulvinar (Pulv) of the L- 
Thal, and (h) Pulv of the R-Thal. 
3.3. Standard voxel-wise permutation tests 
GM reductions in HR and SZ groups relative to HC are shown in 
Table S6 and Fig. S2. 
3.3.1. HR groups vs. controls 
The g-HR group showed no significant cluster of variation. With 
regard to the c-HR group, a very small cluster was detected in the R-ACC. 
3.3.2. SZ groups vs. controls 
Overall, results reported statistically significant clusters largely 
overlapping with those identified by ALE. The RDSZ group showed eight 
clusters of GM reduction involving both cortical and subcortical regions 
with total altered GM volume of 2,246 mm3. Maximum values were 
found in the: (a) L-IFG (BA 45), (b) L-AI (BA 13), (c) L-TTG (BA 41), (d) 
R-MTG (BA 22), (e) bilateral ACC (BA 32/24), and (f) L-PHG (BA 35). 
The ChSZ group showed eight clusters of GM reduction involving both 
cortical and subcortical regions with total altered GM volume of 
17,913 mm3. Maximum values were found in the: (a) L-MFG (BA 10), (b) 
bilateral AI (BA 13), (c) bilateral ACC (BA 32), (d) MDN of the L-Thal, 
and (e) bilateral PHG (BA 34), extending to the (f) amygdalar complex. 
3.4. Behavioral characterization 
Data-driven behavioral analysis revealed that aberrant ALE-derived 
patterns found in the clinical groups can be quantitatively associated 
with a wide range of functional neuroimaging tasks as shown in Fig. 6 
and Tables S7 (RDSZ group) and S8 (ChSZ group). 
We found no significant results associated with the R-ACC cluster in 
the c-HR group, whereas the whole-brain patterns of GM loss in the 
RDSZ and in the ChSZ groups were characterized by a statistically sig-
nificant involvement of numerous different subdomains belonging to all 
five studied domains: cognition, perception, emotion, action and inter-
oception. General distribution of the number of subdomains involved in 
each domain in the two clinical conditions is shown in the radar chart of 
Fig. 6. The ChSZ group, compared to the RDSZ group, displayed a higher 
number of involved subdomains (33 vs. 23). The main difference con-
cerned the emotional domain with nine subdomains involved in the 
ChSZ group compared to the five of the RDSZ one. Fig. 6 (bottom panel) 
shows the ranking of the involved subdomains of the ChSZ group in 
decreasing order of z-score, coupled with the z-score of the corre-
sponding subdomain in the RDSZ group. All the 23 functional sub-
domains found the RDSZ group were also present in the ChSZ group. The 
10 subdomains exclusively associated with the GM loss in the ChSZ 
group were negative emotions (i.e. sadness, anger, unspecified negative 
emotions), positive emotions (i.e. happiness and unspecified positive 
emotions) of the emotion domain; “social cognition” and “memory” of 
the cognitive domain; “olfaction” of the perceptive domain; “inhibition 
of movement” of the action domain; and “sexuality (libido)” of the 
interoception domain. 
Table 1 
Clusters of gray matter reduction derived from the Anatomical Likelihood 
Estimation (ALE) analyses. For each cluster obtained, cluster size (mm3), 
extrema ALE values, anatomical labels of the peaks of probability and their 











x y z 
g-HR < HC 
No cluster found 
c-HR < HC (tot. 800 mm3) 
1 800 Right Anterior 
Cingulate Cortex (BA 
32) 
0.016 4 36 − 6  
RDSZ < HC (tot. 8,360 mm3) 
1 1,776 Left Precentral Gyrus 
(BA 6) 
0.025 − 48 − 10 24   
Left Inferior Frontal 
Gyrus (BA 44) 
0.024 − 48 4 18 
2 1,624 Right Transverse 
Temporal Gyrus (BA 
41) 
0.025 48 − 24 16   
Right Middle 
Temporal Gyrus (BA 
21) 
0.018 54 − 26 − 2 
3 1,296 Right Middle 
Temporal Gyrus (BA 
22) 
0.023 50 − 8 − 8   
Right Insula (BA 13) 0.022 40 − 10 − 6 
4 1,096 Left Insula (BA 13) 0.031 − 32 22 4 
5 1,032 Left Transverse 
Temporal Gyrus (BA 
41) 
0.024 − 46 − 18 10   
Left Superior 
Temporal Gyrus (BA 
22) 
0.020 − 52 − 8 6 
6 784 Left Anterior 
Cingulate (BA 32) 
0.022 − 2 34 − 4   
Right Anterior 
Cingulate (BA 32) 
0.020 2 40 2 
7 752 Left Amygdala 0.023 − 20 − 4 − 18   
Left Parahippocampal 
Gyrus (BA 34) 
0.015 − 12 0 − 14  
ChSZ < HC (tot. 14,912 mm3) 
1 4,928 Left Insula (BA 13) 0.042 − 34 18 6   
Left Superior 
Temporal Gyrus (BA 
22) 
0.035 − 48 4 2   
Left Insula (BA 13) 0.027 − 44 12 0   
Left Inferior Frontal 
Gyrus (BA 47) 
0.020 − 40 20 − 6 
2 3,056 Right Insula (BA 13) 0.037 40 14 2   
Right Insula (BA 13) 0.035 32 18 8 
3 2,312 Left Thalamus 
(Medial Dorsal 
Nucleus) 
0.036 − 2 − 16 6 
4 1,656 Right Medial Frontal 
Gyrus (BA 11) 
0.032 4 36 − 14   
Right Anterior 
Cingulate (BA 32) 
0.031 4 32 − 6 
5 1,224 Left Caudate (Nucleus 
Head) 
0.036 − 4 6 − 4 
6 1,056 Left Amygdala 0.036 − 20 − 6 − 12 
7 680 Right Amygdala 0.026 16 − 4 − 16 
g-HR: genetic high-risk; c-HR: clinical high-risk; RDSZ: recently diagnosed 
schizophrenia; ChSZ: chronic schizophrenia; HC: healthy controls. 
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Subdomains associated with single ALE-derived clusters are repre-
sented in Fig. S3 (RDSZ group) and in Fig. S4 (ChSZ group). Of the seven 
ALE-derived clusters of GM reduction found in both the RDSZ and ChSZ 
groups, five clusters in each clinical group were significatively associ-
ated with at least one functional subdomain. In the RDSZ condition, the 
L-IFG was principally associated with action subdomains, bilateral TTG 
with perceptive subdomains, L-Ins with cognitive and action sub-
domains, and the L-Amy with emotional sub-domains. In the ChSZ 
group, bilateral insulae were principally associated with cognitive 
(including social cognitive), perceptive, action and interoceptive sub-
domains, L-Amy with emotional and perceptive sub-domains, L-Thal 
with cognitive subdomains and the L-Caud with reward/gain positive 
emotion subdomain. 
3.5. Network decomposition 
The results of the functional network decomposition analysis are 
shown in Fig. 7 and in Table S9. Fig. 7 (A and B panels) shows the 
subdivision of the morphometric alteration of the clinical groups into 
the different functional networks, while Fig. 7C depicts the percentage 
of altered GM volume in each network (i.e. proportional to the total 
altered GM volume in each clinical group). 
In the c-HR group the ALE-derived cluster of GM alteration belonged 
to (a) the orbitofrontal cortex network - OFC-N (548 mm3, 68.5 % of the 
total altered volume) and to (b) the salience network - SN (252 mm3, 
31.5 %). Most of the altered GM volume of the RDSZ fell within (a) the 
SN (2710 mm3, 32.4 %), (b) the OFC-N (1217 mm3, 14.6 %), (c) the left 
ventral attention network - L-VAN (1198 mm3, 14.3 %), (d) the motor 
network - MN (1115 mm3, 13.3 %), and (e) the sensorimotor network - 
SMN (932 mm3, 11.2 %). In the ChSZ the most involved networks were: 
(a) the SN (4956 mm3, 33.2 %), (b) the OFC-N (3971 mm3, 26.6 %), and 
(c) the thalamus/basal nuclei network - Th-BN-N (2667 mm3, 17.9 %). 
3.6. Effects of meta-regression on GM reduction 
Linear associations between selected clinical and methodological 
variables and VBM data of the included experiments of the whole SZ 
group are shown in Fig. S5 (lower panel), Tables S10 (demographic and 
clinical variables) and S11 (methodological variables) and summarized 
as follows. As expected, the ALE results related to the whole SZ group 
were very similar in terms of spatial convergence with those of the AES- 
SDM (Fig. S5, upper panel). Voxel-wise correlation (i.e. Pearson’s r) 
between the unthresholded ALE and AES-SDM z-score maps was r = .64 
(calculated excluding the non-brain voxels). 
3.6.1. Effects of demographic and clinical variables 
Effect of sex: experiments with higher percentage of male patients 
were associated with a widespread GM loss in the: (a) L-STG (p = 1.0e-5, 
52 voxels); (b) left inferior temporal gyrus (L-ITG; p = 1.0e-4, 46 voxels); 
(c) R-Ins (p = 6.0e-5, 50 voxels); (d) bilateral thalami (p = 5.0e-6, 94 
voxels). 
Effect of antipsychotic treatment: in experiments with higher per-
centage of medicated patients compared with studies with a higher 
percentage of drug-naïve patients at the scan time, we found a more 
widespread decrease of the GM volumes of (a) the L-MFG (p = 2.0e-4, 39 
voxels) and of (b) the R-STG (p = 2.0e-5, 127 voxels). 
Antipsychotic dosage, age at scan and positive and negative symp-
toms: no linear associations with age at scan, medication dosage 
Fig. 2. Brain clusters of convergent GM reduction in the clinical high-risk (c-HR) group compared to healthy controls (HC). Results are FWE-corrected at .05 with 
cluster-forming value at p < .001. The ALE maps are visualized as three hemispheric surfaces (3-D cortical view) and five axial slices (2-D cortical and subcortical 
view). Brain templates are in neurological convention (i.e. R is right, L is left). 
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(chlorpromazine mg equivalents), positive and negative symptoms 
(PANSS positive and negative scores) were found. 
3.6.2. Effects of methodological variables 
Sample size: experiments with smaller sample size showed a more 
widespread GM decrease volume in (a) the right STG (R-STG), extending 
to (b) the R-Ins (p = 4.0e-7, 293 voxels) and in a small cluster located (c) 
in the L-ACC (p = 1.0e-5, 28 voxels). 
Image smoothing level (FWHM): higher smoothing was significantly 
associated with GM reduction in (a) the R-Ins, extending to (b) the R- 
PrCG (p = 1.0e-4, 86 voxels) and in the (c) L-STG (p = 1.0e-4, 27 voxels). 
Field strength and slice thickness: linear associations with VBM data 
and these variables were not found. 
4. Discussion 
By reviewing a vast literature of voxel-based neuroimaging studies 
about schizophrenia, this meta-analysis offers the most overarching 
picture of morphometric changes of GM currently available and lends 
support to pathophysiological models, which combine progressive brain 
alterations with the clinical evolution of SZ. Using a conservative study 
selection and the current state-of-the-art methods in the CBMA field, we 
have identified GM alterations associated with clinical high-risk sub-
jects, recently diagnosed and chronic patients with SZ, providing meta- 
analytical evidence of progressive brain morphometric changes after 
prodromal symptoms and signs onset. As a distinguishing feature of this 
study, we have established an objective link between the SZ symptom-
atology and the underlying neural pathophysiology, associating the 
resulting GM changes with data-driven functional profile 
characterizations. Our findings also demonstrate between-study effects 
of sex, sample size and medication on published VBM results. 
4.1. GM alterations partly reproduce previous CBMA results on SZ stages 
Our findings are only in part consistent with those of the previous 
meta-analyses on the different stages of SZ, providing new important 
information about the progression of GM alteration during the course of 
the disorder. Interestingly, our analyses showed that there were no 
morphometric differences between g-HR and HC groups. This result is in 
line with a recent CBMA of VBM studies on first degree relatives of pa-
tients with SZ (Saarinen et al., 2020), but not with previous in-
vestigations reporting GM tissue loss at the level of the R-ACC and L-PHG 
(Fusar-Poli et al., 2011a, 2014). The lack of significant findings may be 
explained by a variety of factors. For example, as early meta-analytic 
syntheses have been published with significant smaller data sets (i.e. 
less than 10 VBM experiments each) due to the limited availability of 
research data, our results are particularly robust and reasonably 
non-driven by singly experiments (Eickhoff et al., 2016). It is worth 
noting that the mean age at the scan of the first/second degree relative 
varies widely across experiments (Table S2), which increases the 
between-study variability. Also, it has been suggested that specific 
morphometric brain variations in g-HR subjects may be present only in 
those who develop psychosis later in life (Smieskova et al., 2010, 2013). 
However, as these subjects represent a small portion of the g-HR pop-
ulation (Fusar-Poli et al., 2012), their contribution could be covered by 
the substantial number of the non-transitioning subjects. 
Regarding c-HR group, we confirmed the GM loss in the R-ACC found 
in previous CBMAs (Chan et al., 2011; Fusar-Poli et al., 2011a). 
Fig. 3. Brain clusters of convergent GM reduction in the recently diagnosed schizophrenia (RDSZ) group compared to healthy controls (HC). Results are FWE- 
corrected at .05 with cluster-forming value at p < .001. The ALE maps are visualized as three hemispheric surfaces (3-D cortical view) and five axial slices (2-D 
cortical and subcortical view). Brain templates are in neurological convention. 
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However, the R-AI, L-Amy and L-IFG clusters found by Chan et al. 
(2011), and the R-STG, L-PHG, L-AI, R-IFG ones found by Fusar-Poli 
et al. (2011a) have not survived our rigorous thresholding procedure. 
Moreover, unlike early meta-analyses (Boos et al., 2007), we have not 
replicated the hippocampal reduction in HR groups, probably due to our 
whole-brain approach, which has selectively excluded studies using ROI 
or SVC analyses on this region (McDonald et al., 2008). 
In the RDSZ group, we confirmed the findings that the L-IFG, L-Amy 
and bilateral ACC show GM decreases (Chan et al., 2011; Ellison-Wright 
et al., 2008), but not the findings of GM reduction in the caudate, 
thalamus and cerebellum. In this group, we have also revealed GM al-
terations in the temporal cortices, bilateral insula and L-PHG, which 
were associated with ChSZ patients only in those previous in-
vestigations. For what concerns the ChSZ group, we confirmed the 
presence of bilateral GM alterations in the AI, ACC, and amygdala. The 
left IFG was also found by early CBMAs (Chan et al., 2011; Ellison--
Wright et al., 2008). Furthermore, we revealed a cluster of GM reduction 
in the bilateral thalamus, which was only left-lateralized in Chan et al. 
(2011), and in the left caudate head, which was not found in the pre-
vious ALE studies. It should be noted that the involvement of the 
aforementioned regions in SZ groups was confirmed by the standard 
voxel-wise permutation tests. Taking this into account, it is reasonable to 
assume that our state-of-the-art multiple-comparison corrections ensure 
an adequate type I error control than the liberal (but previously 
employed) FDR correction, as the latter is prone to reveal false positive 
findings in meta-analytic neuroimaging investigations (Eickhoff et al., 
2016, 2017; Müller et al., 2017; Nani et al., 2019; Samea et al., 2019). 
Another important result of the present work that contrasts with 
previous ALE investigations (Chan et al., 2011; Ellison-Wright and 
Bullmore, 2010; Fornara et al., 2017; Fornito et al., 2009) is the sys-
tematic absence of the lingual and fusiform gyri, cuneus, posterior 
cingulate and cerebellum in the SZ clinical groups. As to this aspect, we 
note that these posterior areas were found altered in a relatively small 
number of included studies. Therefore, the discrepancy may be due to 
the fact that our statistical inference was more sensitive to large effects, 
and less affected by individual experiments (Eickhoff et al., 2017, 2016). 
Finally, our results fit well with findings of white matter (WM) degen-
eration. In previous studies (Bora et al., 2011; Vitolo et al., 2017) the 
anterior part of the corpus callosum, the anterior thalamic radiation, 
inferior longitudinal and fronto-occipital fasciculi, cingulate bundle and 
fornix were associated to SZ. Notably, these tracts connect GM regions 
that have been found to be decreased in at least one of the stages. For 
instance, the anterior corpus callosum might contribute to abnormalities 
in interhemispheric communication between the AIs during the pro-
gression of the disorder, in agreement with studies reporting volumetric 
alteration of right deep prefrontal-insular WM and a widespread 
disruption of right genu of the corpus callosum in ChSZ individuals 
(Mitelman et al., 2009; Spalletta et al., 2015; Sugranyes et al., 2012). To 
note, long association tracts connecting bilateral ACC, AI and medial 
prefrontal cortex have been found altered in SZ (Bora et al., 2011; Reid 
et al., 2016), and also the aberration of bilateral anterior thalamic ra-
diation is a well-replicated finding in chronic stage of the disease (Canu 
et al., 2015; Li et al., 2017). Taken in this context, GM findings of the 
present study are in line with fronto-striatal and temporo-limbic systems 
disruption as well as evidence regarding progressive disconnection of 
the brain in SZ. 
Fig. 4. Brain clusters of convergent GM reduction in the chronic schizophrenia (ChSZ) group compared to healthy controls (HC). Results are FWE-corrected at .05 
with cluster-forming value at p < .001. The ALE maps are visualized as three hemispheric surfaces (3-D cortical view) and five axial slices (2-D cortical and 
subcortical view). Brain templates are in neurological convention. 
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4.2. Differences and overlaps between clinical groups: evidence for a 
typical progression of the GM loss 
While none of the meta-analytic works to date assessed an objective 
overlap estimation between the c-HR, RDSZ and ChSZ groups, here we 
have quantitatively evaluated the conjunction areas of alteration, in 
parallel with the differential areas emerging from the between groups 
comparisons. The contrast ALE analyses showed that the RDSZ group 
report a larger brain volume characterized by GM reduction compared 
to c-HR group, suggesting an important enlargement of altered ence-
phalic areas during the first period of full-blown non-affective psychosis. 
We found a similar trend in the second comparison: recently diagnosed 
versus chronic SZ. In this case, the two groups differ significantly for 
mean age, duration of illness and for the total volume of GM decrease 
(Tables 2 and S4). 
The strong increment in the GM reduction found in the post-onset 
phase of SZ may be explained by the fact that the c-HR groups include 
heterogeneous subclinical psychopathological states that not neces-
sarily, and in a relatively small proportion (approximately 36 % after 3 
years from the first evaluation), will transition into a diagnosis of SZ 
(Falkenberg et al., 2015; Fusar-Poli et al., 2012). In addition, the first 
months after the onset of the disorder are considered the most critical in 
influencing prognosis and the most correlated to neurotoxic processes, 
especially if the patient is not correctly and promptly diagnosed and 
treated (Anderson et al., 2014). 
The R-ACC is the only cluster found among c-HR subjects and is also 
present in the SZ groups, suggesting a potential significant role of this 
area in the development and progression of the disorder. Both structural 
and functional aberrations of the R-ACC are well-replicated findings in 
different cohorts of individuals at high clinical-risk for psychosis (Allen 
et al., 2010; Fornito et al., 2008; Fusar-Poli et al., 2011a, b; Fusar-Poli 
et al., 2014; Jessen et al., 2006; Shim et al., 2010; Takayanagi et al., 
2017). Moreover, this anatomical region was recently proposed as being 
the epicenter of neuronal volume loss in SZ (Shafiei et al., 2020). 
Therefore, the ACC volumetric loss could represent a neuroimaging 
marker of SZ both before (that is, in the prodromal phase with a putative 
prognostic significance of transition to SZ) and after the onset of the 
disorder. However, further research is needed to unravel this issue, 
especially on patients who later develop psychosis and with the help of 
harmonized longitudinal protocols to increase comparability across 
Table 2 
Clusters of gray matter difference and conjunction derived from the Anatomical Likelihood Estimation (ALE) analyses. For each cluster obtained, cluster size (mm3), 
extrema values, anatomical labels of the peaks of probability and their Talairach brain atlas coordinates were provided.  
Cluster # Volume (mm3) Talairach Daemon Label (Brodmann’s Area) Extrema Value 
Talairach 
x y z 
c-HR U RDSZ (tot. 144 mm3) 
1 144 Right Anterior Cingulate Cortex (BA 32) 0.014 2 36 − 6  
c-HR < RDSZ   
No cluster found      
RDSZ < c-HR (tot. 2,600 mm3) 
1 1,032 Left Superior Temporal Gyrus (BA 22) p < .001 − 50.2 − 13.3 8.4   
Left Insula (BA 13) p < .001 − 47.3 − 18.7 16 
2 768 Left Postcentral Gyrus (BA 43) p < .001 − 50 − 10 16   
Left Precentral Gyrus (BA 4) p = .001 − 51.6 − 12 24.4 
3 576 Left Insula (BA 13) p = .001 − 32 12 8   
Left Insula (BA 13) p = .002 − 36 13 5   
Left Claustrum p = .005 − 30 18 2   
Left Inferior Frontal Gyrus (BA 45) p = .009 − 32 24 6 
4 224 Left Insula (BA 13) p = .002 − 46 4 14   
Left Inferior Frontal Gyrus (BA 44) p = .003 − 49.5 1 15.5  
RDSZ U ChSZ (tot. 1,184 mm3) 
1 680 Left Insula (BA 13) 0.029 − 32 20 4 
2 304 Left Amygdala 0.023 − 20 − 4 − 16 
3 120 Left Anterior Cingulate (BA 32) 0.020 0 34 − 4 
4 56 Left Precentral Gyrus (BA 6) 0.018 − 52 − 6 6 
5 24 Left Inferior Frontal Gyrus (BA 47) 0.016 − 48 6 14  
RDSZ < ChSZ (tot. 672 mm3) 
1 520 Left Precentral Gyrus (BA 6) p = .001 − 49 − 5 24.4   
Left Postcentral Gyrus (BA 43) p = .002 − 50 − 8.5 17.5   
Left Inferior Frontal Gyrus (BA 44) p = .004 − 49 0 20 
2 136 Left Postcentral Gyrus (BA 43) p = .006 − 47 − 17 14   
Left Insula (BA 13) p = .007 − 46 − 14 10 
3 16 Right Medial Temporal Gyrus (BA 21) p = .006 44 − 8 − 12  
ChSZ < RDSZ (tot. 1,464 mm3) 
1 672 Right Parahippocampal Gyrus (BA 34) p < .001 12.8 − 3.6 − 16   
Right Uncus (BA 34) p = .001 17.7 − 4.4 − 19 
2 480 Left Thalamus (Medial Dorsal Nucleus) p = .001 − 7 − 20 11   
Right Thalamus (Pulvinar) p = .002 4 − 24 9   
Left Thalamus (Pulvinar) p = .003 − 3.5 − 23 4.5 
3 256 Left Precentral Gyrus (BA 44) p = .001 − 46 12 8   
Left Insula (BA 13) p = .005 − 44 0 2 
4 40 Right Insula (BA 13) p = .003 36 20 2 
5 16 Left Superior Temporal Gyrus (BA 22) p = .01 − 51 8 4 
g-HR: genetic high-risk; c-HR: clinical high-risk; RDSZ: recently diagnosed schizophrenia; ChSZ: chronic schizophrenia; HC: healthy controls.. <: Indicates that the gray 
matter (GM) reduction is wider in the group to the left of the symbol. U: indicates the clusters of GM volume reduction found in the groups both to the left and to the 
right of the symbol. 
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multiple sites (Andreou and Borgwardt, 2020; Cannon et al., 2014; 
Fusar-Poli et al., 2012). 
When compared to the c-HR group, the RDSZ condition shows 4 
leftward clusters of higher GM reduction, located in the frontal, parietal, 
temporal, insular cortices and in the subcortical region of the claustrum 
(Table 2). These results suggest a typical diffusion of GM decrease across 
left hemispheric cortical areas, which can be detected in the first months 
after the onset of the disorder (Takahashi and Suzuki, 2018). Interest-
ingly, our findings align with both theoretical and experimental pro-
posals suggesting a prominent abnormal left asymmetry of neural 
systems in SZ driven by volumetric reductions (Oertel et al., 2010; 
Oertel-Knöchel and Linden, 2011; Ribolsi et al., 2014). The cortical 
involvement of the left hemisphere in early stages of SZ was also 
described by recent resting-state functional connectivity MRI studies (Li 
et al., 2019c, 2017; Wang et al., 2019), which outlined a prevalence of 
reduced leftward interactions between the functional networks involved 
in language, interoceptive awareness, auditory and sensory processing. 
Furthermore, the volumetric reduction of highly connected anatomical 
structures (such as the AI, STG, IFG and claustrum) is consistent with the 
pathophysiological model proposed by Palaniyappan (2017), according 
to which a GM dysfunctional remodeling takes place in topologically 
important hubs of the brain, mostly in the immediate post-onset phase of 
SZ, thus representing an adaptive but inefficient compensatory response 
to the disorder itself. 
RDSZ and ChSZ conditions share convergent patterns of volumetric 
GM loss preferentially in the left hemisphere (i.e. IFG, PrCG, AI and 
Amy), except for the bilateral cluster of ACC (Fig. 5). These higher-order 
integration areas were repeatedly found altered in both the recently 
diagnosed and chronic populations, and related to the wide range of 
signs and symptoms of SZ (Jeong et al., 2009; Killgore et al., 2009; 
Shepherd et al., 2012; Wylie and Tregellas, 2010; Yan et al., 2012). It is 
worth noting that these regions partially overlap with the cortical dis-
tribution of the Von Economo Neurons (VENs), large spindle-bipolar 
neuronal cells, mostly located in layer V of the AI and of the ACC (All-
man et al., 2010, 2011). VENs are also present in great apes and other 
mammalians and are associated with “social brain” abilities (Butti et al., 
2013; Cauda et al., 2014). Alterations of this neuronal subpopulation in 
post-mortem histological studies were associated with SZ (Brüne et al., 
2010, 2011; Krause et al., 2017). Overall, results are to be interpreted 
with caution as these neuroanatomical regions were also recently clas-
sified as brain hubs with high structural alteration variety, which is to say 
that they can be affected by a wide range of psychiatric and neurological 
disorders (Cauda et al., 2019; Crossley et al., 2014; Liloia et al., 2018). 
Following this view, the development of ‘reverse inference’ methodol-
ogies (e.g. advanced computational tools based on Bayesian statistic 
inference) is needed to better define neural substrates that are specific to 
SZ. 
Contrast analyses between SZ groups highlight the presence of areas 
of volumetric loss, which are specific to either the recent diagnosis or to 
the chronic conditions. A selective GM reduction, found in the RDSZ 
Fig. 5. Conjunction and contrast analyses between clinical groups. (A) Convergence of GM reduction between clinical-high risk and recently diagnosed schizo-
phrenia groups (colors from dark to light blue represent increasing ALE values). (B) Compared to the clinical-high risk group, GM reductions are exclusively present 
in the recently diagnosed schizophrenia patients (colors from dark to light red represent increasing z-point values). (C) Convergence of GM reduction between 
recently diagnosed and chronic schizophrenia groups (colors from dark to light blue represent increasing ALE values). (D) Compared to the chronic schizophrenia 
group, GM reductions are exclusively present in the recently diagnosed patients (colors from dark to light green represent increasing z-point values). Compared to the 
recently diagnosed schizophrenia group, GM reductions are exclusively present in the chronic patients (colors from dark to light red represent increasing z-point 
values). ALE results were computed using a p value < .01 and minimum cluster-size > 10 mm3. 
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group only, belongs to cortical areas of the frontal, parietal and insular 
lobes of the left hemisphere and, to a lesser extent, to the right temporal 
lobe. The leftward temporal and prefrontal clusters observed in the 
RDSZ patients might suggest some form of dysfunctional compensation 
or reorganization mechanism that might take place just after the 
disruption caused in the acute phase of the first episode of psychosis 
(Palaniyappan, 2017). 
In the ChSZ group five clusters of more marked GM reduction have 
been found in both cerebral hemispheres, showing a left-to-right and 
cortical-to-subcortical enlargement that appears to affect the bilateral 
AI, PHG, Amy, Thal (pulvinar and medial dorsal nuclei) and the STG. 
This robust finding is significant, given that GM reductions occurring 
homotopically have been underemphasized by previous voxel-based 
investigations. It also worth noting that both cross-sectional and longi-
tudinal approaches have so far collected conflicting results for para-
hippocampal and amygdalar involvement at different phases of SZ 
(Shepherd et al., 2012). In accordance with some studies (Asami et al., 
2012; Chan et al., 2011; Davidson and Heinrichs, 2003; Velakoulis et al., 
2000; Wright et al., 2000), our results underline that abnormalities of 
the left amygdala-parahippocampal complex are present during the first 
stages of SZ and that the involvement of the right complex is likely to 
reflect the chronicity of the disorder. Furthermore, recent studies re-
ported a disrupted interhemispheric coordination in terms of altered 
functional connectivity and white matter tracts in subjects with SZ 
(Hoptman et al., 2012; Liu et al., 2018; Sun et al., 2015). Interestingly, 
new lines of research support the idea that GM tissue damage in SZ is 
constrained by brain pathways (Cauda et al., 2018; Shafiei et al., 2020), 
and intimately related to homotopic interactions (Mancuso et al., 2019). 
These findings emphasize the role of aberrant connections linking 
homotopic areas in the development of SZ. 
Although thalamic anomalies are well known to be implicated in the 
SZ condition (Pergola et al., 2015), some meta-analytical investigations 
found significant volumetric reductions of this diencephalic structure 
starting from the early phase of illness (Adriano et al., 2010; Ellison--
Wright et al., 2008), and others in the chronic stage only (Bora et al., 
2011) or exclusively left-lateralized in ChSZ (Chan et al., 2011). This 
inconsistency is not entirely surprising: different results could be due to 
the limited MRI resolution, heterogeneity in meta-data selection, study 
design, as well as to different methodological procedures. The present 
ALE meta-analysis highlights a selective involvement of L-MDN and 
bilateral pulvinar in the ChSZ condition, which accords well with some 
neuroimaging and post-mortem studies (Brickman et al., 2004; Byne 
et al., 2001, 2009; Horga et al., 2011; Kemether et al., 2003; Pergola 
et al., 2015; Shimizu et al., 2008). 
Even if the neurobiological agents underlying these changes remain 
largely unknown and the role of structural and functional connectivity 
in the GM progression is still an open issue in SZ and other neuropsy-
chiatric disorders (Cauda et al., 2019), the marked increase of the GM 
volume reduction found in the three stages of the disorder here analyzed 
(c-HR < RDSZ < ChSZ) is consistent with the contemporary pathophys-
iological models of SZ, which describe altered neurodevelopmental long 
term processes accompanied by neuroprogression phenomena 
Fig. 6. Behavioral characterization results of whole ALE-derived brain maps of GM reduction obtained in the RDSZ and ChSZ groups. (Upper panel) Alteration 
patterns are visualized as two axial slices (3-D cortical and subcortical view). (Central panel) Number of subdomains significantly associated in each domain. (Bottom 
panel) Z-scores of significant subdomains. A threshold of p < .05 with Bonferroni correction for multiple comparisons was applied, corresponding to a subdomain z- 
scores ≥ 3. 
GM: gray matter; ACC: anterior cingulate cortex; Ins: insula; IFG: inferior frontal gyrus; TTG: transverse temporal gyrus; Amy: amygdala; Caud: caudate; 
Thal: thalamus. 
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(Andreasen, 2010; Ashe et al., 2001; Keshavan, 1999; Palaniyappan, 
2017). 
4.3. Behavioral characterization: unbiased evidence for a link between 
GM alterations and psychological features of the disorder 
The progression of GM alteration from the RSDZ condition to the 
ChSZ one has its counterpart in the functional characterization, as all the 
behavioral subdomains found in the RDSZ group are shared by the ChSZ 
subjects, who show many other involved mental processes. 
Auditive perceptive and phonologic linguistic subdomains exhibit 
the higher z-scores in the RDSZ condition. The GM reduction associated 
with the auditive alteration is in agreement with a higher prevalence of 
positive symptoms in the first months after the onset of the disorder, 
such as paracusia (Fountoulakis et al., 2019, 2020), while the phono-
logic linguistic involvement may be lead to the negative symptoms 
affecting language processes (Compton et al., 2018). Among these 
symptoms, aprosody, a specific aspect of the vocal blunted affect, 
defined as the reduced ability to produce the melodic line of speech 
thanks to variations in pitch, rhythm, and stress of pronunciation, has 
been recently associated with patients with a shorter DOI (Compton 
et al., 2018). Focusing on GM alteration at a single cluster-level in RDSZ, 
we find the involvement of linguistic and action speech subdomains 
associated with the GM reduction in the L-IFG cluster, and of perceptive 
subdomains (audition and pain) connected with the bilateral TTG 
clusters. The L-IFG is considered a central node of human brain, impli-
cated in semantic and affective integration during communication 
(Belyk et al., 2017); its volumetric reduction and dysconnectivity in the 
first phases of SZ has been associated to linguistic, memory and 
encoding impairment (Bonner-Jackson et al., 2005; Chen et al., 2014; 
Jeong et al., 2009). 
With regard to common subdomains shared by the two SZ groups, 
two clusters of GM reduction emerge: L-Ins and L-Amy. The L-Ins cluster 
suggests an involvement of several cognitive functions, including 
attention, reasoning, language, working and explicit memory and music 
comprehension, as well as of action subdomains like execution of speech 
and inhibition of movement. These data-driven associations accord well 
with the findings of Liao et al. (2015), who found positive correlations 
between the GM volume of the L-Ins and performance at the Digit 
Symbol Substitution Test (DSST; Jaeger, 2018) in a large cohort of pa-
tients with SZ. 
To note, this region has been recently found to predict treatment 
response and clinical prognosis of both RDSZ and ChSZ patients (Li et al., 
2019b; Mikolas et al., 2016), showing an important role in the patho-
physiology of SZ. In both SZ groups, the L-Amy cluster was linked to 
negative emotional, explicit memory and visual perception functions. 
Functional MRI studies report aberrant amygdalar activation in SZ, 
showing patterns of hypo-connectivity with the insula and IFG during 
emotional and social recognition tasks (Mier et al., 2019; Mukherjee 
et al., 2014). 
In ChSZ several mental processes, relating to neurocognition (i.e. 
attention and reasoning), language (i.e. speech and semantics), reward/ 
gain positive emotion and sexuality (i.e. libido) show a high z-score at 
cluster-level. The neurocognitive impairment, especially the deficits in 
Fig. 7. Functional network decomposition of the ALE-derived clusters of GM reduction obtained in the c-HR, RDSZ and ChSZ groups. (A and B) Graphical repre-
sentations of the number of altered volumes (mm3) falling within a functional network. (C) Graphical representation of the altered volumes falling within a functional 
network (percentage). 
AuN: auditory network; DMN: default mode network; preMN: premotor network; R-VAN: right ventral attention networks; DAN: dorsal attention network; SMN: 
sensorimotor network; MN: motor network; L-VAN: left ventral attention networks; Th-BN-N: thalamus-basal nuclei subcortical network; OFC-N: orbito-frontal cortex 
network; SN: salience network. 
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attentional functions, is a typical trait of SZ (Green et al., 2019; Kahn and 
Keefe, 2013), which is present since the prodromal phase with important 
worsening at the illness onset and a slower increment during its pro-
gression (Seidman and Mirsky, 2017). In this regard, we observe that a 
previous voxel-based investigation of ChSZ subjects (Schiffer et al., 
2010) showed significant associations between GM volume of frontal/-
cingulate cortex and planning performance, reasoning, and executive 
inhibition. 
The involvement of cognitive functions related to language produc-
tion can partially explain the negative symptomatology of SZ, in 
particular some expression deficits like alogia, and aprosody (Compton 
et al., 2018). We suppose a similar correlation between the involvement 
of the reward/gain emotional processes and the pole of reduced moti-
vation of the negative symptoms, interpreted as a product of the reduced 
ability to expect and feel pleasure during activities (anhedonia) and the 
reduced ability to start actions and projects (avolition) (Lee et al., 2015). 
The high engagement of emotional subdomains, defined as the “mental 
faculty of experiencing an affective state of consciousness” (http://bra 
inmap.org/taxonomy/behaviors.html), including positive and negative 
emotion like reward/gain, happiness, fear, sadness, disgust, anxiety and 
anger, may represent a neuroanatomical counterpart of the blunted 
affect dimension of negative symptoms. More generally, the significant 
involvement in the ChSZ group of mental processes theoretically related 
to negative symptoms is concordant with the high prevalence of this 
type of symptoms in the chronic condition (Fountoulakis et al., 2019, 
2020). Indeed, primary persistent negative symptoms still represent an 
unmet need in the care of patients with SZ (Mucci et al., 2017). Finally, 
the GM reduction of cerebral areas correlated with sexual interoception 
is in line with the evidence of deficits in sexual cognition and fantasy 
arousal found in unmedicated patients with SZ: these deficits, therefore, 
are not necessarily secondary to the antipsychotic treatment (Dem-
bler-Stamm et al., 2018). 
4.4. Functional networks and their relationship with different SZ stages 
Most of the altered GM volume in each clinical group belongs to 
encephalic regions that are key nodes of the SN, which is composed by 
the ACC, the ventral part of the PrCG (BA 6, pre-SMA) and the AI (Seeley 
et al., 2007). The pivotal role played by this functional network in the 
psychopathology of SZ is supported by numerous studies that found 
associations between structural and functional alteration of the SN and 
the core symptoms and the prognosis of the disorder (Li et al., 2019b; 
Palaniyappan and Liddle, 2012). Moreover, in agreement with our re-
sults, alteration of the SN was found in all the SZ stages (Mallikarjun 
et al., 2018; Spreng et al., 2019; Wang et al., 2016). The SN is thought to 
be responsible for dynamic switching between default mode and 
task-related states of the brain, and is engaged in a plethora of tasks 
involving interoceptive, action, perceptive and cognitive domains 
(Menon and Uddin, 2010; Uddin, 2015). Our behavioral characteriza-
tion accords well with this evidence. 
In terms of absolute number of volumes associated, the OFC-N was 
the most functional network involved in the c-HR group, with the 
following progression between the three clinical groups: c- 
HR < RDSZ < ChSZ. The importance of the OFC-N in the prodromal 
phase of SZ was emphasized by Collin et al. (2018), who found that the 
OFC resting-state functional connectivity (rsFC) is a distinctive trait of 
the c-HR subjects that, after the MR scan, transition into overt psychosis. 
The OFC-N is involved in the inference of the expected outcomes’ values. 
This inference ability is impaired when the rsFC of the OFC is reduced 
with targeted transcranial magnetic stimulation (Howard et al., 2020). 
Therefore, a GM decrease of OFC-N cortical areas could be related to the 
prodromal negative symptoms, particularly to the motivational deficits 
that are frequently found in c-HR subjects and heavily impact on quality 
of life (Glenthoj et al., 2020). 
Morphometric variations of RDSZ appear to accumulate preferen-
tially in specific functional systems, namely L-VAN, MN and SMN. GM 
reductions of the BA 44, 45 and 47 located in the L-IFG correspond to a 
selective involvement of the L-VAN, that is thought to be involved in 
reorienting attention toward unattended stimuli (Corbetta et al., 2002). 
This result accords well with the evidence of altered connectivity of the 
VAN in patients in the SZ early-stage (Hummer et al., 2020). However, it 
should be noted that the involvement of the R-VAN is almost exclusive to 
the ChSZ condition; it might therefore be considered as the functional 
counterpart of the homotopic progression (from left to right) of the GM 
alteration. 
A significant GM decrease of the BAs 6 and 4, which are parts of the 
MN, is specifically found in the RDSZ condition. In particular, the pri-
mary motor area (M1) corresponds to the BA 4 and the premotor area 
(PMA), while the supplementary motor area (SMA) and the pre-SMA 
partly belong to the BA 6. Our findings are in agreement with previ-
ous studies showing alteration of M1 and SMA connectivity in SZ, after 
controlling for age and antipsychotic medications (Bernard et al., 2017), 
as well as alteration of the BA 6 correlated with abnormal involuntary 
movements in RDSZ patients (Kindler et al., 2019). 
The specific GM reduction of the pars opercularis of the PoCG (BA 43), 
which constitutes part of the secondary somatosensory area (S2), cor-
responds to the selective involvement of the SMN found in the RDSZ 
group. This network is involved in auditory, visual, tactile and direct 
pain perception, social perception (observation of the stimulus percep-
ted by others), and empathetic accuracy tasks (judging the meaning of 
the social stimulus) (Keysers et al., 2010; Paracampo et al., 2017). The 
SMN dysconnectivity has been associated with multiple transdiagnostic 
dimensions of psychopathology in different major psychiatric disorders, 
including SZ (Kebets et al., 2019). Furthermore, a recent study on RDSZ 
subjects demonstrated how, in this specific phase of the disorder, 
sensorimotor conflictual stimuli could induce failure in bodily 
self-monitoring by generating presence hallucination, that is, by making 
patients wrongly perceive a person standing behind themselves (Salo-
mon et al., 2020). 
GM reductions in the bilateral thalami (MDN and pulvinar) and in 
the head of the left caudate have been specifically associated with the 
ChSZ group. In this group such GM loss may reflect the greater 
involvement of the Th-BN-N at both absolute and relative levels. This 
result is in line with a recent study on ChSZ patients (mean DOI > 15 
years) that reported a hypo-connection of the SN with the MDN of the 
thalamus, the ventral parts of striatum and the pallidum, and a hyper- 
connection of the SMN with the anterior ventral nucleus of the thal-
amus and the dorsal striatum, which includes the caudate nucleus 
(Avram et al., 2018). Thus, according to this evidence and to our results, 
it is likely a progressive involvement of subcortical “relays” structures as 
SZ develops. This engagement might play a role in the dysconnectivity 
and altered integration of other functional networks, such as the SN, MN 
and the SMN (Ferri et al., 2018; Hua et al., 2019; Skåtun et al., 2018). 
4.5. Effects of clinical and methodological variables 
Our voxel-wise meta-regression approach suggests that gender, an-
tipsychotics, sample size and imaging smoothing level had significant 
effects on GM alterations across experiments. The result of widespread 
brain abnormalities in patients’ groups with higher percentage of male is 
not surprising in SZ literature. Similarly to Bora et al. (2011), our results 
reveal a GM negative relationship related to the L-IFG, R-Ins, and 
bilateral thalamus in samples with a higher percentage of male patients. 
Volumetric variations have been related to different GM decreases in 
male/female patients with SZ (Mendrek and Mancini-Marïe, 2016), 
which to some extent may reflect different gender health development 
(Lotze et al., 2019). 
Groups with a high percentage of patients undergoing antipsychotic 
treatment have been associated with more severe GM loss in the L-MFG, 
R-STG, and R-Ins. At present, the association between the antipsychotic 
medication and regional anatomical changes in SZ remains inconsistent 
(Lawrie, 2018). Taken in this context, our results provide voxel-based 
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evidence of localized effects related to antipsychotic drug usage. 
Cautious interpretations are needed due to the lack of longitudinal 
approach and the unappreciated contribution of other variables such as 
the severity of symptoms, which could variously correlate with an 
antipsychotic treatment and its duration, dosage and typology, as well as 
a more or less marked GM alteration (Fusar-Poli et al., 2013; Vita et al., 
2015). 
Small sample size impacts on GM findings in a double cluster of 
alteration, corresponding to the R-STG and the L-ACC. This result is 
consistent with a number of studies highlighting the importance of 
sufficiently large sample sizes in neuroimaging investigations in order to 
enhance reproducibility and decrease between-study heterogeneity 
(Chen et al., 2018; Ingre, 2013; Lorca-Puls et al., 2018). Although the 
CBMA approach tends to mitigate these issues, our findings further 
highlight that it is advisable to increase the number of patients to pro-
vide more robust results. 
The absence of significant linear effect on GM volumes with chlor-
promazine equivalents could be explained by the heterogeneity of 
antipsychotic drugs and of the times of exposure to the drugs (Vita et al., 
2015). A similar explanation concerns the absence of linear association 
between positive and negative symptoms and GM alterations. These two 
dimensions of symptoms were evaluated with the PANSS positive and 
negative subscales, that include many items poorly correlated with these 
two symptomatic constructs, therefore introducing “noise” in the data 
(Fountoulakis et al., 2019). More specific and targeted evaluations of 
signs and symptoms of SZ, possibly based on the factor analysis of the 
PANSS (Kay et al., 1987) and taking into account also disorganized, 
depressive and cognitive symptoms, should be recommended in all 
neuroimaging studies on SZ in order to better detect significant corre-
lation between imaging and specific aspects of the disorder. 
4.6. Innovation and strengths 
Our work partially confirms the results of the previous CBMAs about 
SZ stages and provides new evidence for their better characterization. 
First, we were able to include the largest number of published experi-
ments due to the rapid growth of the field. The balance between sensi-
tivity and susceptibility to false positive effects was therefore maximized 
and the power of the meta-analysis increased (Müller et al., 2018). 
Second, published articles that pooled together both patients with 
short and long duration of illness were excluded and studies about HR 
were included, allowing us to study morphological and functional pat-
terns related to specific stages of the disorder, including the prodromal 
phase, so as to exclude possible confounding elements derived from 
other diagnosis belonging to the SSD. For the comparisons between 
clinical groups we added a set of conjunction and contrast analyses, 
allowing us to statistically derive common and potentially distinctive 
neuroanatomical markers. 
Third, we employed a new revised version of the ALE method and 
implemented a conservative thresholding. To our knowledge, this is the 
first ALE study on SZ using both the corrected GingerALE version and 
cluster-level FWE correction, ensuring an adequate type I error control 
and the maximum statistical rigor (Eickhoff et al., 2017, 2016). 
Importantly, the involvement of ALE-derived brain regions was further 
demonstrated via voxel-wise permutation tests. 
Fourth, we found the neuroanatomical effects of male sex, sample 
size, image smoothing level and medication. Although these results 
should be interpreted with caution, as meta-regression tested the mean- 
relation between samples (Radua et al., 2012) and a different algorithm 
than ALE was employed, they might shed light on the impact of certain 
variables on GM findings, as well as improve future sampling and 
methodological strategies. 
Fifth, the quantitative functional characterization used in this study 
ensured a comprehensive and objective behavioral association to GM 
findings, and explored mental functions prominently linked to different 
stages of SZ. This choice was motivated by the long-standing debate 
concerning the limits of observer-dependent and region-to-behavior 
inference in the field of neuroimaging (Scarpazza and De Simone, 2016). 
4.7. Limitations and challenges 
The present study has general limitations inherent to meta-analytic 
approach. The ALE technique is based on stereotactic foci reported by 
published articles and, therefore, may be potentially affected by the 
publication bias against null results (i.e. file-drawer problem) (Müller 
et al., 2018). Other bias could relate to the selective local maxima 
evaluation, excluding the remaining significant voxels of variation. 
However, it should be noted this standardized procedure in the neuro-
imaging field and in CBMA, can decrease the probability of making 
spatial errors (Eickhoff et al., 2009; Radua et al., 2012). We also note 
that the incomplete reporting of included investigations data may 
hamper some meta-regression results. For instance, a number of studies 
do not provided information about medication dosage (49/90 studies, 
54.5 % of the total) or PANSS positive and negative scores (34/90 
studies, 37.7 % of the total). 
Finally, it is important to point out that our approach cannot deter-
mine causality of illness progression due to the lack of longitudinal 
design. However, robust cross-sectional meta- and mega-analyses are 
also essential to further clarify this issue and build a more integrative 
view (Meisenzahl et al., 2008; Pantelis et al., 2005; Torres et al., 2016; 
Zhao et al., 2018). In this regard, our approach has been highly sensitive 
in quantifying more widespread structural changes in the chronic con-
dition than in the first period after the onset of the disorder; in addition, 
it has been able to identify certain common alteration patterns that 
could represent critical starting points in the propagation of damage and 
clinical manifestations of the disease. 
Although we have consolidated the existing literature by identifying 
the ‘if’ and ‘where’ of GM changes in SZ, future investigations are 
needed to detect ‘how’ these changes co-occur in a network-like archi-
tecture and diffuse at different stages of disease. Moreover, the devel-
opment of novel ‘reverse inference’ methodologies is greatly needed in 
order to disentangle the pathological brain landscape, as well as to 
identify the cerebral regions exhibiting high alteration specificity for the 
SZ condition. 
5. Conclusions 
This meta-analysis provides a quantitative summary of voxel-based 
results on different stages of SZ published over the last two-decades. 
Our findings support the current framework that considers SZ as a 
neurodevelopmental disease with a neuroprogressive component, but 
also update and characterize the pathological landscape of SZ stages. 
The heterogeneity in the underlying literature notwithstanding, we have 
found high-quality evidence for convergent GM loss in cortico-striatal- 
limbic hub regions. It is worth noting that the GM reduction in the R- 
ACC is present both in the c-HR group and in SZ groups; if confirmed, 
this result would make the alteration of R-ACC a possible marker of 
disease progression. A widespread GM loss has been found in the RDSZ 
patients, mainly in frontal and temporal areas of the left cerebral 
hemisphere. A further spread of the GM reduction in homotopic areas of 
the right hemisphere as well as into subcortical region has been found in 
the ChSZ subjects. Albeit in cross-sectional and meta-analytic manner, 
these results are likely to reflect the temporal progression of SZ and the 
interhemispheric and subcortical diffusion of its neuroanatomical 
alteration. The development of novel neuroimaging methodologies and 
of longitudinal multicenter and multimodal studies is needed to advance 
in this field. We are therefore hopeful that the approach employed here 
may pave the way for research on possible diagnostic and neuroimaging 
biomarkers of SZ staging, as well as on the identification of new thera-
peutics target that could be addressed not only with psychopharmaco-
logical treatments but also with focused magnetic and/or non-invasive 
electric stimulation and with evidence-based psychosocial rehabilitation 
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programs. 
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Projects “Dipartimenti di Eccellenza 2018− 2022” to the Dept. of 
Neuroscience “Rita Levi Montalcini” (P Rocca, PI). 
CRediT authorship contribution statement 
Donato Liloia: Conceptualization, Methodology, Formal analysis, 
Investigation, Data curation, Writing - original draft, Visualization. 
Claudio Brasso: Methodology, Data curation, Writing - original draft. 
Franco Cauda: Writing - review & editing, Supervision, Project 
administration, Funding acquisition. Lorenzo Mancuso: Formal anal-
ysis, Writing - review & editing. Andrea Nani: Writing - review & 
editing. Jordi Manuello: Investigation. Tommaso Costa: Writing - re-
view & editing, Formal analysis, Investigation, Supervision. Sergio 
Duca: Project administration. Paola Rocca: Writing - review & editing, 
Supervision, Project administration, Funding acquisition. 
Declaration of Competing Interest 
The authors report no declarations of interest. 
Appendix A. Supplementary data 
Supplementary material related to this article can be found, in the 
online version, at doi:https://doi.org/10.1016/j.neubiorev.2021.01.0 
10. 
References 
Adriano, F., Spoletini, I., Caltagirone, C., Spalletta, G., 2010. Updated meta-analyses 
reveal thalamus volume reduction in patients with first-episode and chronic 
schizophrenia. Schizophr. Res. 123, 1–14. https://doi.org/10.1016/j. 
schres.2010.07.007. 
Albajes-Eizagirre, A., Radua, J., 2018. What do results from coordinate-based meta- 
analyses tell us? NeuroImage 176, 550–553. https://doi.org/10.1016/j. 
neuroimage.2018.04.065. 
Albajes-Eizagirre, A., Solanes, A., Vieta, E., Radua, J., 2019. Voxel-based meta-analysis 
via permutation of subject images (PSI): theory and implementation for SDM. 
NeuroImage 186, 174–184. https://doi.org/10.1016/j.neuroimage.2018.10.077. 
Albrecht, F., Bisenius, S., Neumann, J., Whitwell, J., Schroeter, M.L., 2019. Atrophy in 
midbrain & cerebral/cerebellar pedunculi is characteristic for progressive 
supranuclear palsy - A double-validation whole-brain meta-analysis. Neuroimage 
Clin. 22, 101722 https://doi.org/10.1016/j.nicl.2019.101722. 
Allen, P., Stephan, K.E., Mechelli, A., Day, F., Ward, N., Dalton, J., Williams, S.C., 
McGuire, P., 2010. Cingulate activity and fronto-temporal connectivity in people 
with prodromal signs of psychosis. NeuroImage 49, 947–955. https://doi.org/ 
10.1016/j.neuroimage.2009.08.038. 
Allman, J.M., Tetreault, N.A., Hakeem, A.Y., Manaye, K.F., Semendeferi, K., Erwin, J.M., 
Park, S., Goubert, V., Hof, P.R., 2010. The von Economo neurons in frontoinsular and 
anterior cingulate cortex in great apes and humans. Brain Struct. Funct. 214, 
495–517. https://doi.org/10.1007/s00429-010-0254-0. 
Allman, J.M., Tetreault, N.A., Hakeem, A.Y., Manaye, K.F., Semendeferi, K., Erwin, J.M., 
Park, S., Goubert, V., Hof, P.R., 2011. The von Economo neurons in the frontoinsular 
and anterior cingulate cortex. Ann. N. Y. Acad. Sci. 1225, 59–71. https://doi.org/ 
10.1111/j.1749-6632.2011.06011.x. 
Anderson, K.K., Voineskos, A., Mulsant, B.H., George, T.P., McKenzie, K.J., 2014. The 
role of untreated psychosis in neurodegeneration: a review of hypothesized 
mechanisms of neurotoxicity in first-episode psychosis. Canadian journal of 
psychiatry. Revue canadienne de psychiatrie 59, 513–517. https://doi.org/10.1177/ 
070674371405901003. 
Andreasen, N.C., 2010. The lifetime trajectory of schizophrenia and the concept of 
neurodevelopment. Dialogues Clin. Neurosci. 12, 409–415. https://doi.org/ 
10.31887/DCNS.2010.12.3/nandreasen. 
Andreou, C., Borgwardt, S., 2020. Structural and functional imaging markers for 
susceptibility to psychosis. Mol. Psychiatry. https://doi.org/10.1038/s41380-020- 
0679-7. 
Asami, T., Bouix, S., Whitford, T.J., Shenton, M.E., Salisbury, D.F., McCarley, R.W., 
2012. Longitudinal loss of gray matter volume in patients with first-episode 
schizophrenia: DARTEL automated analysis and ROI validation. NeuroImage 59, 
986–996. https://doi.org/10.1016/j.neuroimage.2011.08.066. 
Ashburner, J., Friston, K.J., 2000. Voxel-based morphometry—the methods. NeuroImage 
11, 805–821. https://doi.org/10.1006/nimg.2000.0582. 
Ashe, P.C., Berry, M.D., Boulton, A.A., 2001. Schizophrenia, a neurodegenerative 
disorder with neurodevelopmental antecedents. Prog. Neuropsychopharmacol. Biol. 
Psychiatry 25, 691–707. https://doi.org/10.1016/s0278-5846(01)00159-2. 
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